Antimicrobial Stewardship

Latest News

Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews
Xacduro, A New Weapon in the Fight Against Bacterial Pneumonia: Insights From Clinical Trials and Expert Interviews

May 26th 2023

The innovative antibiotic Xacduro has received FDA approval for its efficacy against ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii-calcoaceticus. The intravenous therapy combines sulbactam and durlobactamto target multidrug-resistant and carbapenem-resistant strains.

Infectious Disease Pharmacists Day 2023: Our Top Stories
Infectious Disease Pharmacists Day 2023: Our Top Stories

May 22nd 2023

Rising Threat: Evaluating Salmonella Treatment Options Amid Antimicrobial Resistance
Rising Threat: Evaluating Salmonella Treatment Options Amid Antimicrobial Resistance

May 15th 2023

Antibiotic Shows Noninferiority Vs Colistin for Acinetobacter infections
Antibiotic Shows Noninferiority Vs Colistin for Acinetobacter infections

May 12th 2023

Invasive Fungal Infections in Critically Ill COVID-19 Patients
Invasive Fungal Infections in Critically Ill COVID-19 Patients

May 11th 2023

© 2023 MJH Life Sciences

All rights reserved.